Robert Bucki
Impact in
- Microbiology top 0.1%
- Antimicrobial Peptides and Activities
- Periodontics top 1%
Papers in
-
- Bacterial biofilms and quorum sensing 18
- Biochemical and Structural Characterization 13
- Microbiology 57
- Antimicrobial Peptides and Activities 55
- Co-authors
- Paul A. Janmey (67 shared papers)Ewelina Piktel (79 shared papers)Paul B. Savage (45 shared papers)Katarzyna Niemirowicz (28 shared papers)Fitzroy J. Byfield (21 shared papers)Piotr Deptuła (46 shared papers)Bonita Durnaś (43 shared papers)Tomasz Wollny (23 shared papers)
- Journals
- International Journal of Molecular Sciences (17 papers)Pathogens (9 papers)International Journal of Nanomedicine (8 papers)Scientific Reports (6 papers)Antimicrobial Agents and Chemotherapy (5 papers)
- Partner nations
- PolandUnited StatesFrance
In The Last Decade
Robert Bucki
201 papers receiving 6.4k citations
Robert Bucki's Hit Papers
Peers
Comparison fields: 5 of 168
- Microbiology 1.6k
- Periodontics 249
- Cell Biology 849
- Molecular Medicine 214
- Biomaterials 527
Countries citing papers authored by Robert Bucki
This map shows the geographic impact of Robert Bucki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bucki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bucki more than expected).
Fields of papers citing papers by Robert Bucki
This network shows the impact of papers produced by Robert Bucki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bucki. The network helps show where Robert Bucki may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Bucki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 210 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment Hit paper breakdown → | 2021 | 228 |
| 2 | 2011 | 223 | |
| 3 | 2008 | 189 | |
| 4 | 2010 | 186 | |
| 5 | 2014 | 164 | |
| 6 | 2016 | 144 | |
| 7 | 2003 | 103 | |
| 8 | 2023 | 103 | |
| 9 | 2018 | 102 | |
| 10 | 2013 | 102 | |
| 11 | 2019 | 101 | |
| 12 | 2001 | 99 | |
| 13 | 2021 | 97 | |
| 14 | 2015 | 94 | |
| 15 | 2007 | 92 | |
| 16 | 2008 | 90 | |
| 17 | 2007 | 88 | |
| 18 | 2005 | 87 | |
| 19 | 2015 | 83 | |
| 20 | 2018 | 83 |
About Robert Bucki
Robert Bucki is a scholar working on Molecular Biology, Microbiology, Cell Biology, Physiology and Immunology, having authored 210 papers that have together received 6.5k indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (55 papers), Cellular Mechanics and Interactions (19 papers), Bacterial biofilms and quorum sensing (18 papers), Biochemical and Structural Characterization (13 papers), Oral microbiology and periodontitis research (11 papers), Helicobacter pylori-related gastroenterology studies (10 papers), Nanoparticles: synthesis and applications (10 papers) and Erythrocyte Function and Pathophysiology (9 papers). The work is most often cited by research in Microbiology (1.6k citations), Periodontics (249 citations), Cell Biology (849 citations), Molecular Medicine (214 citations) and Biomaterials (527 citations). Robert Bucki has collaborated with scholars based in Poland, United States and France. Frequent co-authors include Paul A. Janmey, Ewelina Piktel, Paul B. Savage, Katarzyna Niemirowicz, Fitzroy J. Byfield, Piotr Deptuła, Bonita Durnaś, Tomasz Wollny, Alina Kułakowska and Marzena Wątek. Their work appears in journals such as International Journal of Molecular Sciences, Pathogens, International Journal of Nanomedicine, Scientific Reports and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.